Please ensure Javascript is enabled for purposes of website accessibility
Free Article Join Over 1 Million Premium Members And Get More In-Depth Stock Guidance and Research

Cannabis Producers Could Be Making a Colossal Mistake in Dismissing This Threat

By David Jagielski - Oct 21, 2021 at 6:17AM

Key Points

  • The Canadian marijuana market is growing in size, but that doesn't mean large producers are generating staggering revenue growth.
  • Smaller producers that are focused on quality have been taking market share from big-name companies.
  • At the three-year mark of the recreational market opening up in Canada, there are nearly 800 licensed cannabis producers in the country vying for market share.

Motley Fool Issues Rare “All In” Buy Alert

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Craft growers shouldn't be overlooked.

It has now been three full years since Canada legalized the recreational marijuana market on Oct. 17, 2018. In the early stages, marijuana producers in the country were generating strong growth numbers due to the new segment of the market opening up (previously, only medical marijuana had been legal). But fast forward to today, and top companies like Hexo ( HEXO -0.89% ) have been struggling to produce consistent quarter-over-quarter growth.

A big reason: The role of the craft cannabis producer. Smaller companies focused on quality have been able to prevent these larger producers from dominating the industry. They've become thorns in the sides of the bigger players who may not be taking the threat seriously enough.

Two people working in a greenhouse.

Image source: Getty Images.

Multiple companies acknowledge smaller producers, but aren't worried about them -- yet

When cannabis producer Hexo reported its third-quarter earnings (for the period ending April 30) in June, its revenue of 22.7 million Canadian dollars was down 31% from the second quarter, in which sales were CA$32.9 million. CEO Sebastien St. Louis said that some new cannabis strains were lower in quality than the company expected, and that created an opportunity for smaller producers to steal market share, noting that "craft has absolutely surprised us." However, he believes that the company can produce better products on a more consistent basis than craft growers.

Hexo isn't the only company that has faced challenges due to craft. The largest cannabis company in Canada, Tilray ( TLRY -1.27% ), reported its latest results in October. While its sales grew 43% year over year to $168 million for the period ending Aug. 31, which is largely due to the merger with marijuana producer Aphria that closed in May with its results now included in Tilray's overall tally, it too faced challenges from smaller producers that CEO Irwin Simon referred to dismissively as "ankle biters." Tilray's goal is to reach a market share of 30% in the Canadian marijuana market, but analysts today estimate that percentage is closer to 12%.

Dismissing the threat could prove to be costly

Canadian marijuana stocks have been struggling since legalization, largely due to the underwhelming results that producers have been generating since then:

^SPX Chart

^SPX data by YCharts

As of the three-year mark, there are 776 marijuana producers in the country, and oversupply continues to be a problem in the industry. And if companies such as Hexo and Tilray don't take the threat seriously, it could lead to more underwhelming results in the future.

What should investors do?

The role of craft producers isn't proving to be a worry for large multi-state operators in the U.S. because those companies are still in their early growth stages. In Canada, however, the market is well past that point. The market isn't brand new, and terrific sales growth is no longer a guarante; there's loads of competition and companies have to fight for market share. Craft may play a significant role in the U.S. market as well, but for now the growth opportunities there remain plentiful as more states open up for business.

One way investors can look to minimize their risks in the sector is by avoiding companies like Tilray that have ultra-aggressive growth targets (aiming to hit $4 billion in revenue by 2024) and where quality may not be the highest priority -- and given the CEO's comments calling the competition "ankle biters," that only creates more concern that craft isn't being taken seriously. 

There's still considerable risk in the sector. But the safer bet for now is for cannabis investors to focus on marijuana companies that are generating profits and that are at least reporting decent margins on their products, which suggests that there is a focus on quality there (as opposed to low-quality products that would be cheaper in price).

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis – even one of our own – helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

HEXO Stock Quote
HEXO
HEXO
$1.11 (-0.89%) $0.01
Aphria Stock Quote
Aphria
TLRY
$10.12 (-1.27%) $0.13

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning service.

Stock Advisor Returns
673%
 
S&P 500 Returns
142%

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 12/01/2021.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Our Most Popular Articles

Premium Investing Services

Invest better with the Motley Fool. Get stock recommendations, portfolio guidance, and more from the Motley Fool's premium services.